Is my portfolio
One Report to Answer all your Questions!
Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%) Dr Reddy's Laboratories informs about press release
Date: 16-12-2022Dr Reddy's Laboratories has informed that Aurigene Oncology, a wholly owned subsidiary of Dr Reddy's Laboratories, reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis. A press release in this regard is enclosed.
The above information is a part of company’s filings submitted to BSE.